Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant growth hormone in children with juvenile idiopathic arthritis and growth failure
2004-004153-25Phase 4Terminated
- Sponsor
- Royal Hospital for Children and Young People
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of somatropin in juvenile idiopathic arthritis (JIA), sponsored by Royal Hospital for Children and Young People. Started Feb 2005; status: terminated.
02
Drugs
somatropin
03
Conditions
juvenile idiopathic arthritis (JIA)
Beyond the preview
Go deeper on 2004-004153-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004153-25.